Pharmacotherapy of the inner ear

Genes, Hearing, and Deafness: From Molecular Biology to Clinical Practice

Volumn , Issue , 2007, Pages 219-238

  Pyykkö, Ilmari ^a   Toppila, Esko ^b   Zou, Jing ^a   Kentala, Erna ^c  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^b FINNISH INSTITUTE OF OCCUPATIONAL HEALTH   (Finland)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77953033120     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (152)

1. Hu BH, Henderson D, Nicotera TM. Extremely rapid induction of outer hair cell apoptosis in the chinchilla cochlea following exposure to impulse noise. Hear Res 2006; 211(1-2): 16-25.
2. Lynch ED, Kil J. Compounds for the prevention and treatment of noise-induced hearing loss. Drug Discov Today 2005; 10(19): 1291-1298.
3. Kalkanis JG, Whitworth C, Rybak LP. Vitamin E reduces cisplatin ototoxicity. Laryngoscope 2004; 114(3): 538-542.
4. Sha SH, Schacht J. Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant. Hear Res 2000; 142(1-2): 34-40.
5. Van De Water TR et al. Caspases, the enemy within, and their role in oxidative stress-induced apoptosis of inner ear sensory cells. Otol Neurotol 2004; 25(4): 627-632.
6. Sage C, Huang M, Karimi K, et al. Proliferation of functional hair cells in vivo in the absence of the retinoblastoma protein. Science 2005; 307(5712): 1114-1118.
7. Sobkowicz HM, Bereman B, Rose JE. Organotypic development of the organ of Corti in culture. J Neurocytol 1975; 4(5): 543-572.
8. Fekete DM, Muthukumar S, Karagogeos D. Hair cells and supporting cells share a common progenitor in the avian inner ear. J Neurosci 1998; 18(19): 7811-7821.
9. Gopfert MC, Stocker H, Robert D. Atonal is required for exoskeletal joint formation in the Drosophila auditory system. Dev Dyn 2002; 225(1): 106-109.
10. Izumikawa M et al. Auditory hair cell replacement and hearing improvement by Atoh1 gene therapy in deaf mammals. Nat Med 2005; 11(3): 271-276.
11. Cacace AT, Silver SM, Farber M. Rapid recovery from acoustic trauma: chicken soup, potato knish, or drug interaction? Am J Otolaryngol 2003; 24(3): 198-203.
12. Henderson D et al. The role of antioxidants in protection from impulse noise. Ann N Y Acad Sci 1999; 884: 368-380.
13. Ulfendahl M, Khanna SM, Heneghan C. Shearing motion in the hearing organ measured by confocal laser heterodyne interferometry. Neuroreport 1995; 6(8): 1157-1160.
14. Ulehlova L. Stria vascularis in acoustic trauma. Arch Otorhinolaryngol 1983; 237(2): 133-138.
15. Tsuprun V et al. Structure of the stereocilia side links and morphology of auditory hair bundle in relation to noise exposure in the chinchilla. J Neurocytol 2003; 32(9): 1117-1128.
16. Scheibe F, Haupt H, Ludwig C. Intensity-dependent changes in oxygenation of cochlear perilymph during acoustic exposure. Hear Res 1992; 63(1-2): 19-25.
17. Leon Y, Sanchez-Galiano S, Gorospe I. Programmed cell death in the development of the vertebrate inner ear. Apoptosis 2004; 9(3): 255-264.
18. Jokay I et al. Apoptosis in the human inner ear. Detection by in situ end-labeling of fragmented DNA and correlation with other markers. Hear Res 1998; 117(1-2): 131-139.
19. Nakashima T et al. Disorders of cochlear blood flow. Brain Res Brain Res Rev 2003; 43(1): 17-28.
20. Lamm K, Arnold W. Successful treatment of noise-induced cochlear ischemia, hypoxia, and hearing loss. Ann N Y Acad Sci 1999; 884: 233-248.
21. Lamm K, Arnold W. The effect of blood flow promoting drugs on cochlear blood flow, perilymphatic pO(2) and auditory function in the normal and noise-damaged hypoxic and ischemic guinea pig inner ear. Hear Res 2000; 141(1-2): 199-219.
22. Lamm K, Arnold W. Noise-induced cochlear hypoxia is intensity dependent, correlates with hearing loss and precedes reduction of cochlear blood flow. Audiol Neurootol 1996; 1(3): 148-160.
23. Banfi B et al. NOX3, a superoxide-generating NADPH oxidase of the inner ear. J Biol Chem 2004; 279(44): 46065-46072.
24. Yamashita D et al. Post-exposure treatment attenuates noiseinduced hearing loss. Neuroscience 2005; 134(2): 633-642.
25. Budihardjo I et al. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269-290.
26. Slee EA, Adrain C, Martin SJ. Executioner caspase-3, -6, and -7 perform distinct, non-redundant roles during the demolition phase of apoptosis. J Biol Chem 2001; 276(10): 7320-7326.
27. Maier JK et al. The neuronal apoptosis inhibitory protein is a direct inhibitor of caspases 3 and 7. J Neurosci 2002; 22(6): 2035-2043.
28. Hu BH, Henderson D, Nicotera TM. F-actin cleavage in apoptotic outer hair cells in chinchilla cochleas exposed to intense noise. Hear Res 2002; 172(1-2): 1-9.
29. Pomerantz JL, Baltimore D. NF-kappaB activation by a signaling complex containing TRAF2, TANK and TBK1, a novel IKKrelated kinase. Embo J 1999; 18(23): 6694-6704.
30. Alam SA et al. The expression of apoptosis-related proteins in the aged cochlea of Mongolian gerbils. Laryngoscope 2001; 111(3): 528-534.
31. Zou J et al. Sensorineural hearing loss after vibration: an animal model for evaluating prevention and treatment of inner ear hearing loss. Acta Otolaryngol 2001; 121(2): 143-148.
32. Puel JL et al. Excitotoxicity and repair of cochlear synapses after noise-trauma induced hearing loss. Neuroreport 1998; 9(9): 2109-2114.
33. Hildebrand MS et al. Characterisation of DRASIC in the mouse inner ear. Hear Res 2004; 190(1-2): 149-160.
34. Waldmann R et al. A proton-gated cation channel involved in acid-sensing. Nature 1997; 386(6621): 173-177.
35. Fridberger A, Ulfendahl M. Acute mechanical overstimulation of isolated outer hair cells causes changes in intracellular calcium levels without shape changes. Acta Otolaryngol 1996; 116(1): 17-24.
36. Maurer J, Heinrich UR, Mann W. Morphologic damage and changes of intracellular calcium-binding sites after acute noise trauma in the organ of Corti of the guinea pig. ORL J Otorhinolaryngol Relat Spec 1993; 55(1): 7-12.
37. Fridberger A, van Maarseveen JT, Ulfendahl M. An in vitro model for acoustic overstimulation. Acta Otolaryngol 1998; 118(3): 352-361.
38. Pomerantz JL, Baltimore D. Signal transduction. A cellular rescue team. Nature 2000; 406(6791): 26-27, 29.
39. Hoeflich KP et al. Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 2000; 406(6791): 86-90.
40. Satoh H et al. Proinflammatory cytokine expression in the endolymphatic sac during inner ear inflammation. J Assoc Res Otolaryngol 2003; 4(2): 139-147.
41. Goeddel DV. Signal transduction by tumor necrosis factor: the Parker B. Francis Lectureship. Chest 1999; 116(1 suppl): 69S-73S.
42. Nam YJ et al. Upregulation of glial cell line-derived neurotrophic factor (GDNF) in the rat cochlea following noise. Hear Res 2000; 146(1-2): 1-6.
43. Zou J et al. Vibration induced hearing loss in guinea pig cochlea: expression of TNF-alpha and VEGF. Hear Res 2005; 202(1-2): 13-20.
44. Turner CH, Forwood MR, Otter MW. Mechanotransduction in bone: do bone cells act as sensors of fluid flow? Faseb J 1994; 8(11): 875-878.
45. Abumiya T et al. Shear stress induces expression of vascular endothelial growth factor receptor Flk-1/KDR through the CTrich Sp1 binding site. Arterioscler Thromb Vasc Biol 2002; 22(6): 907-913.
46. Chintalgattu V, Nair DM, Katwa LC. Cardiac myofibroblasts: a novel source of vascular endothelial growth factor (VEGF) and its receptors Flt-1 and KDR. J Mol Cell Cardiol 2003; 35(3): 277-286.
47. Gan L et al. Distinct regulation of vascular endothelial growth factor in intact human conduit vessels exposed to laminar fluid shear stress and pressure. Biochem Biophys Res Commun 2000; 272(2): 490-496.
48. Milkiewicz M et al. Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo. Microcirculation 2001; 8(4): 229-241.
49. Weis SM, Cheresh DA. Pathophysiological consequences of VEGF-induced vascular permeability. Nature 2005; 437(7058): 497-504.
50. Van Campen LE et al. Oxidative DNA damage is associated with intense noise exposure in the rat. Hear Res 2002; 164(1-2): 29-38.
51. Yamane H et al. Appearance of free radicals in the guinea pig inner ear after noise-induced acoustic trauma. Eur Arch Otorhinolaryngol 1995; 252(8): 504-508.
52. Ohlemiller KK, Wright JS, Dugan LL. Early elevation of cochlear reactive oxygen species following noise exposure. Audiol Neurootol 1999; 4(5): 229-236.
53. Ravi R, Somani SM, Rybak LP. Mechanism of cisplatin ototoxicity: antioxidant system. Pharmacol Toxicol 1995; 76(6): 386-394.
54. Lautermann J et al. Glutathione-dependent antioxidant systems in the mammalian inner ear: effects of aging, ototoxic drugs and noise. Hear Res 1997; 114(1-2): 75-82.
55. Rybak LP, Somani S. Ototoxicity amelioration by protective agents. Ann N Y Acad Sci 1999; 884: 143-151.
56. Wu WJ, Sha SH, Schacht J. Recent advances in understanding aminoglycoside ototoxicity and its prevention. Audiol Neurootol 2002; 7(3): 171-174.
57. Clerici WJ, Yang L. Direct effects of intraperilymphatic reactive oxygen species generation on cochlear function. Hear Res 1996; 101(1-2): 14-22.
58. Yamasoba T et al. Attenuation of cochlear damage from noise trauma by an iron chelator, a free radical scavenger and glial cell line-derived neurotrophic factor in vivo. Brain Res 1999; 815(2): 317-325.
59. Kopke RD et al. Reduction of noise-induced hearing loss using LNAC and salicylate in the chinchilla. Hear Res 2000; 149(1-2): 138-146.
60. Zou J et al. Comparison of the protective efficacy of neurotrophins and antioxidants for vibration-induced trauma. ORL J Otorhinolaryngol Relat Spec 2003; 65(3): 155-161.
61. Puka-Sundvall M, Eriksson P, Nilsson M, Sandberg M, Lehmann A. Neurotoxicity of cysteine: intraction with glutamate. Brain Res 1995; 705(1-2): 65-70.
62. Nordang L, Cestreicher E, Arnold W, Anniko M. Glutamate is the afferent neurotransmitter in the human cochlea. Acta otalaryngol 2000; 120(3): 359-362.
63. Attias J et al. Oral magnesium intake reduces permanent hearing loss induced by noise exposure. Am J Otolaryngol 1994; 15(1): 26-32.
64. Ward WD, Glorig A. The relation between vitamin A and temporary threshold shift. Acta Otolaryngol 1960; 52: 72-78.
65. Martin JG. The treatment of acute acoustic trauma (blast injury) with dextran 40 [author’s transl.]. HNO 1977; 25(10): 349-352.
66. Eibach H. Borger U. Therapeutic results in acute acoustic trauma [author’s transl.]. Arch Otorhinolaryngol 1980; 226(3): 177-186.
67. Probst R et al. A randomized, double-blind, placebo-controlled study of dextran/pentoxifylline medication in acute acoustic trauma and sudden hearing loss. Acta Otolaryngol 1992; 112(3): 435-443.
68. Eibach H, Borger U. Acute acoustic trauma. The therapeutic effect of bencyclan in a controlled clinical trial [author’s transl.]. HNO 1979; 27(5): 170-175.
69. Pilgramm M, Schumann K. Hyperbaric oxygen therapy for acute acoustic trauma. Arch Otorhinolaryngol 1985; 241(3): 247-257.
70. Joachims Z et al. Oral magnesium supplementation as prophylaxis for noise-induced hearing loss: results of a double blind field study. Schriftenr Ver Wasser Boden Lufthyg 1993; 88: 503-516.
71. Pilgramm M et al. Do magnesium infusions protect the inner ear during middle ear surgery? A randomized double blind study. Schriftenr Ver Wasser Boden Lufthyg 1993; 88: 517-528.
72. Maurer J et al. Diltiazem for prevention of acoustical trauma during otologic surgery. ORL J Otorhinolaryngol Relat Spec 1995; 57(6): 319-324.
73. Ohinata Y, Miller JM, Schacht J. Protection from noise-induced lipid peroxidation and hair cell loss in the cochlea. Brain Res 2003; 966(2): 265-273.
74. Attanasio G et al. Protective effect of allopurinol in the exposure to noise pulses. Acta Otorhinolaryngol Ital 1999;19(1): 6-11.
75. Seidman MD, Shivapuja BG, Quirk WS. The protective effects ofallopurinol and superoxide dismutase on noise-induced cochlear damage. Otolaryngol Head Neck Surg 1993; 109(6): 1052-1056.
76. Bergmann K. Experiments on the medicamental treatment of the noise-induced cochlear damage. Part I. The effect of dipyridamol and allopurinol on the RMP of the cochlea (guinea pig) after noise [author’s transl.]. Arch Otorhinolaryngol 1976; 212(3): 171-177.
77. Ashkenazi A, Dixit VM. Death receptors: signaling and modulation. Science 1998; 281(5381): 1305-1308.
78. Pavalko FM et al. Fluid shear stress inhibits TNF-alpha-induced apoptosis in osteoblasts: a role for fluid shear stress-induced activation of PI3-kinase and inhibition of caspase-3. J Cell Physiol 2003; 194(2): 194-205.
79. Charles P et al. Regulation of cytokines, cytokine inhibitors, and acute-phase proteins following anti-TNF-alpha therapy in rheumatoid arthritis. J Immunol 1999; 163(3): 1521-1528.
80. Rahman MU, Poe DS, Choi HK. Etanercept therapy for immune-mediated cochleovestibular disorders: preliminary results in a pilot study. Otol Neurotol 2001; 22(5): 619-624.
81. Satoh H et al. Tumor necrosis factor-alpha, an initiator, and etanercept, an inhibitor of cochlear inflammation. Laryngoscope 2002; 112(9): 1627-1634.
82. Wang M, Bregenholt S, Petersen JS. The cholera toxin B subunit directly costimulates antigen-primed CD4 _ T cells ex vivo. Scand J Immunol 2003; 58(3): 342-349.
83. Matteson EL et al. Etanercept therapy for immune-mediated cochleovestibular disorders: a multi-center, open-label, pilot study. Arthritis Rheum 2005; 53(3): 337-342.
84. Vidal F, Fontova R, Richart C. Severe neutropenia and thrombocytopenia associated with infliximab. Ann Intern Med 2003; 139(3): 235.
85. Cheifetz A et al. The incidence and management of infusion reactions to infliximab: a large center experience. Am J Gastroenterol 2003; 98(6): 1315-1324.
86. Ruan RS, Leong SK, Yeoh KH. Ototoxicity of sodium nitroprusside is not due to nitric oxide. Exp Neurol 1999; 158(1): 192-201.
87. Zdanski CJ et al. Nitric oxide synthase is an active enzyme in the spiral ganglion cells of the rat cochlea. Hear Res 1994; 79(1-2): 39-47.
88. Pujol R et al. Pathophysiology of the glutamatergic synapses in the cochlea. Acta Otolaryngol 1993; 113(3): 330-334.
89. Matsuda K et al. A role of glutamate in drug-induced ototoxicity: in vivo microdialysis study combined with on-line enzyme fluorometric detection of glutamate in the guinea pig cochlea. Brain Res 2000; 852(2): 492-495.
90. Johnson KL et al. Role of nitric oxide in kainic acid-induced elevation of cochlear compound action potential thresholds. Acta Otolaryngol 1998; 118(5): 660-665.
91. Irons-Brown SR, Jones TA. Effects of selected pharmacological agents on avian auditory and vestibular compound action potentials. Hear Res 2004; 195(1-2): 54-66.
92. Amaee FR et al. Possible involvement of nitric oxide in the sensorineural hearing loss of bacterial meningitis. Acta Otolaryngol 1997; 117(3): 329-336.
93. Barkdull GC et al. Cochlear microperfusion: experimental evaluation of a potential new therapy for severe hearing loss caused by inflammation. Otol Neurotol 2005; 26(1): 19-26.
94. Denk DM et al. Caroverine in tinnitus treatment. A placebocontrolled blind study. Acta Otolaryngol 1997; 117(6): 825-830.
95. Kopke RD et al. Candidate’s thesis: enhancing intrinsic cochlear stress defenses to reduce noise-induced hearing loss. Laryngoscope 2002; 112(9): 1515-1532.
96. Jager W et al. Noise-induced aspartate and glutamate efflux in the guinea pig cochlea and hearing loss. Exp Brain Res 2000; 134(4): 426-434.
97. Bienkowski P et al. Ototoxic mechanism of aminoglycoside antibiotics-role of glutaminergic NMDA receptors. Pol Merkuriusz Lek 2000; 9(52): 713-715.
98. Puel JL et al. Alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid electrophysiological and neurotoxic effects in the guinea-pig cochlea. Neuroscience 1991; 45(1): 63-72.
99. Schindler RA et al. Enhanced preservation of the auditory nerve following cochlear perfusion with nerve growth factors. Am J Otol 1995; 16(3): 304-309.
100. Staecker H et al. NT-3 and/or BDNF therapy prevents loss of auditory neurons following loss of hair cells. Neuroreport 1996; 7(4): 889-894.
101. Altschuler RA et al. Rescue and regrowth of sensory nerves following deafferentation by neurotrophic factors. Ann N Y Acad Sci 1999; 884: 305-311.
102. Pirvola U et al. The site of action of neuronal acidic fibroblast growth factor is the organ of Corti of the rat cochlea. Proc Natl Acad Sci U S A 1995; 92(20): 9269-9273.
103. Keithley EM et al. GDNF protects the cochlea against noise damage. Neuroreport 1998; 9(10): 2183-2187.
104. Ylikoski J et al. Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 1998; 124(1-2): 17-26.
105. Shoji F et al. Differential protective effects of neurotrophins in the attenuation of noise-induced hair cell loss. Hear Res 2000; 146(1-2): 134-142.
106. Kawamoto K et al. Hearing and hair cells are protected by adenoviral gene therapy with TGF-beta1 and GDNF. Mol Ther 2003; 7(4): 484-492.
107. Low W et al. Basic fibroblast growth factor (FGF-2) protects rat cochlear hair cells in organotypical culture from aminoglycoside injury. J Cell Physiol 1996; 167(3): 443-450.
108. Yamasoba T et al. Absence of hair cell protection by exogenous FGF-1 and FGF-2 delivered to guinea pig cochlea in vivo. Noise Health 2001; 3(11): 65-78.
109. Yamagata T et al. Delayed neurotrophic treatment preserves nerve survival and electrophysiological responsiveness in neomycindeafened guinea pigs. J Neurosci Res 2004; 78(1): 75-86.
110. Wheeler EF et al. Expression of BDNF and NT-3 mRNA in hair cells of the organ of Corti: quantitative analysis in developing rats. Hear Res 1994; 73(1): 46-56.
111. Zheng JL, Stewart RR, Gao WQ. Neurotrophin-4/5 enhances survival of cultured spiral ganglion neurons and protects them from cisplatin neurotoxicity. J Neurosci 1995; 15(7 Pt 2): 5079-5087.
112. Pirvola U et al. Expression of neurotrophins and Trk receptors in the developing, adult, and regenerating avian cochlea. J Neurobiol 1997; 33(7): 1019-1033.
113. Staecker H et al. NT-3 combined with CNTF promotes survival of neurons in modiolus-spiral ganglion explants. Neuroreport 1995; 6(11): 1533-1537.
114. Conroy PJ. New quinolone/steroid combination for topical treatment of acute otitis: early- and late-phase study results. Ear Nose Throat J 2003; 82(8 suppl 2): 2-4.
115. Bachmann G et al. Permeability of the round window membrane for prednisolone-21-hydrogen succinate. Prednisolone content of the perilymph after local administration vs. systemic injection. Hno 2001; 49(7): 538-542.
116. Parnes LS, Sun AH, Freeman DJ. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope 1999; 109(7 Pt 2): 1-17.
117. Chandrasekhar SS et al. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg 2000; 122(4): 521-528.
118. Ikeda K, Morizono T. Effect of ototopic application of a corticosteroid preparation on cochlear function. Am J Otolaryngol 1991; 12(3): 150-153.
119. Jinn TH et al. Determination of ototoxicity of common otic drops using isolated cochlear outer hair cells. Laryngoscope 2001; 111(12): 2105-2108.
120. Kroin JS, Schaefer RB, Penn RD. Chronic intrathecal administration of dexamethasone sodium phosphate: pharmacokinetics and neurotoxicity in an animal model. Neurosurgery 2000; 46(1): 178-182; discussion 182-183.
121. Nordang L, Linder B, Anniko M. Morphologic changes in round window membrane after topical hydrocortisone and dexamethasone treatment. Otol Neurotol 2003; 24(2): 339-343.
122. Spandow O, Anniko M, Hellstrom S. Hydrocortisone applied into the round window niche causes electrophysiological dysfunction of the inner ear. ORL J Otorhinolaryngol Relat Spec 1989; 51(2): 94-102.
123. Lamm K, Arnold W. The effect of prednisolone and non-steroidal anti-inflammatory agents on the normal and noisedamaged guinea pig inner ear. Hear Res 1998; 115(1-2): 149-161.
124. Arriaga MA, Goldman S. Hearing results of intratympanic steroid treatment of endolymphatic hydrops. Laryngoscope 1998; 108(11 Pt 1): 1682-1685.
125. Barrs DM et al. Intratympanic steroid injections for intractable Meniere’s disease. Laryngoscope 2001; 111(12): 2100-2104.
126. Hirvonen TP, Peltomaa M, Ylikoski J. Intratympanic and systemic dexamethasone for Meniere’s disease. ORL J Otorhinolaryngol Relat Spec 2000; 62(3): 117-120.
127. Kitahara T et al. Effects of exposing the opened endolymphatic sac to large doses of steroids to treat intractable Meniere’s disease. Ann Otol Rhinol Laryngol 2001; 110(2): 109-112.
128. Sakata E et al. Treatment of Meniere’s disease. Middle ear infusion with lidocaine and steroid solution. Auris Nasus Larynx 1986; 13(2): 79-89.
129. Sennaroglu L et al. Transtympanic dexamethasone application in Meniere’s disease: an alternative treatment for intractable vertigo. J Laryngol Otol 1999; 113(3): 217-221.
130. Sennaroglu L et al. Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere’s disease. Otolaryngol Head Neck Surg 2001; 125(5): 537-543.
131. Shea JJ Jr, Ge X. Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere’s disease. Otolaryngol Clin North Am 1996; 29(2): 353-358.
132. Silverstein H et al. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose Throat J 1996; 75(8): 468-471, 474, 476 passim.
133. Silverstein H et al. Dexamethasone inner ear perfusion for the treatment of Meniere’s disease: a prospective, randomized, double- blind, crossover trial. Am J Otol 1998; 19(2): 196-201.
134. Sakata E, Itoh A, Itoh Y. Treatment of cochlear-tinnitus with dexamethasone infusion into the tympanic cavity. Int Tinnitus J 1996; 2: 129-135.
135. Sakata E, Ito Y, Itoh A. Clinical experiences of steroid targeting therapy to inner ear for control of tinnitus. Int Tinnitus J 1997; 3(2): 117-121.
136. Kopke RD et al. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otol Neurotol 2001; 22(4): 475-479.
137. Lefebvre PP, Staecker H. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Otolaryngol 2002; 122(7): 698-702.
138. Milewski C, Dornhoffer J, DeMeester C. Possibilities for preserving hearing in labyrinth fistulas of different degrees of severity. Laryngorhinootologie 1995; 74(7): 408-412.
139. Wang J et al. A peptide inhibitor of c-Jun N-terminal kinase protects against both aminoglycoside and acoustic trauma-induced auditory hair cell death and hearing loss. J Neurosci 2003; 23(24): 8596-8607.
140. Vives E, Brodin P, Lebleu B. A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem 1997; 272(25): 16010-16017.
141. Maroney AC et al. Cep-1347 (KT7515), a semisynthetic inhibitor of the mixed lineage kinase family. J Biol Chem 2001; 276(27): 25302-25308.
142. Harris C, Maroney AC, Johnson EM Jr. Identification of JNK-dependent and -independent components of cerebellar granule neuron apoptosis. J Neurochem 2002; 83(4): 992-1001.
143. Ip YT, Davis RJ. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 1998; 10(2): 205-219.
144. Bodner A et al. Mixed lineage kinase 3 mediates gp120IIIB-induced neurotoxicity. J Neurochem 2002; 82(6): 1424-1434.
145. Bonny C et al. Cell-permeable peptide inhibitors of JNK: novel blockers of beta-cell death. Diabetes 2001; 50(1): 77-82.
146. Barr RK, Kendrick TS, Bogoyevitch MA. Identification of the critical features of a small peptide inhibitor of JNK activity. J Biol Chem 2002; 277(13): 10987-10997.
147. Wang LH, Besirli CG, Johnson EM Jr. Mixed-lineage kinases: a target for the prevention of neurodegeneration. Annu Rev Pharmacol Toxicol 2004; 44: 451-474.
148. Ylikoski J et al. Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death. Hear Res 2002; 166(1-2): 33-43.
149. Stjernschantz J, Wentzel P, Rask-Andersen H. Localization of prostanoid receptors and cyclo-oxygenase enzymes in guinea pig and human cochlea. Hear Res 2004; 197(1-2): 65-73.
150. Escoubet B et al. Prostaglandin synthesis by the cochlea of the guinea pig. Influence of aspirin, gentamicin, and acoustic stimulation. Prostaglandins 1985; 29(4): 589-599.
151. Rask-Andersen H et al. Effects of intratympanic injection of latanoprost in Meniere’s disease: a randomized, placebo-controlled, double-blind, pilot study. Otolaryngol Head Neck Surg 2005; 133(3): 441-443.
152. Zou J et al. MRI evidence of exogenous vascular endothelial growth factor-enhanced transport across inner ear barriers in guinea pigs. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 2005; 40(4): 266-270.